Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C N Baker

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Diagnostic Microbiology and Infectious Disease|March 1, 1988
Methods for determining susceptibility of fastidious and unusual pathogens to selected antimicrobial agentsC Thornsberry, J M Swenson, C N Baker, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1980
Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibioticsR N Jones, C Thornsberry, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1981
Antibacterial activity of fortimicin A compared with those of five other aminoglycosides, and factors affecting susceptibility testsC Thornsberry, A L Barry, R N Jones, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1980
Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycinC Thornsberry, A L Barry, R N Jones, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1979
Piperacillin susceptibility tests by the single-disk agar diffusion techniqueA L Barry, C Thornsberry, R E Badal, et al.
Journal of Clinical Microbiology|November 1, 1992
Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacinA L Barry, J H Jorgensen, D J Hardy, et al.
Journal of Clinical Microbiology|February 1, 1991
Campylobacter butzleri sp. nov. isolated from humans and animals with diarrheal illnessJ A Kiehlbauch, D J Brenner, M A Nicholson, et al.
Annals of Internal Medicine|June 1, 1989
Infection caused by Francisella philomiragia (formerly Yersinia philomiragia). A newly recognized human pathogenJ D Wenger, D G Hollis, R E Weaver, et al.
Journal of Clinical Microbiology|April 1, 1987
Campylobacter hyointestinalis associated with human gastrointestinal disease in the United StatesP Edmonds, C M Patton, P M Griffin, et al.
Journal of Clinical Microbiology|November 1, 1995
Genotypic and phenotypic characterization of Helicobacter cinaedi and Helicobacter fennelliae strains isolated from humans and animalsJ A Kiehlbauch, D J Brenner, D N Cameron, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Diagnostic Microbiology and Infectious Disease|March 1, 1988
Methods for determining susceptibility of fastidious and unusual pathogens to selected antimicrobial agentsC Thornsberry, J M Swenson, C N Baker, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1980
Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibioticsR N Jones, C Thornsberry, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1981
Antibacterial activity of fortimicin A compared with those of five other aminoglycosides, and factors affecting susceptibility testsC Thornsberry, A L Barry, R N Jones, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1980
Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycinC Thornsberry, A L Barry, R N Jones, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1979
Piperacillin susceptibility tests by the single-disk agar diffusion techniqueA L Barry, C Thornsberry, R E Badal, et al.
Journal of Clinical Microbiology|November 1, 1992
Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacinA L Barry, J H Jorgensen, D J Hardy, et al.
Journal of Clinical Microbiology|February 1, 1991
Campylobacter butzleri sp. nov. isolated from humans and animals with diarrheal illnessJ A Kiehlbauch, D J Brenner, M A Nicholson, et al.
Annals of Internal Medicine|June 1, 1989
Infection caused by Francisella philomiragia (formerly Yersinia philomiragia). A newly recognized human pathogenJ D Wenger, D G Hollis, R E Weaver, et al.
Journal of Clinical Microbiology|April 1, 1987
Campylobacter hyointestinalis associated with human gastrointestinal disease in the United StatesP Edmonds, C M Patton, P M Griffin, et al.
Journal of Clinical Microbiology|November 1, 1995
Genotypic and phenotypic characterization of Helicobacter cinaedi and Helicobacter fennelliae strains isolated from humans and animalsJ A Kiehlbauch, D J Brenner, D N Cameron, et al.
Pageof 6